The San Francisco tech startup, Atomwise, that develops artificial intelligence systems using powerful deep learning algorithms and supercomputers for drug discovery announced it has raised $45 million Series A to become the preferred artificial intelligence partner for the global pharmaceutical …

Link to Full Article: Read Here

Pin It on Pinterest

Share This

Join Our Newsletter

Sign up to our mailing list to receive the latest news and updates about and the Informed.AI Network of AI related websites which includes Events.AI, Neurons.AI, Awards.AI, and Vocation.AI

You have Successfully Subscribed!